{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:48:53Z","timestamp":1791931733892,"version":"4.3.4"},"reference-count":37,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recent population-based studies demonstrate an increased fracture risk with monoclonal gammopathy of undetermined significance (MGUS). The etiology of this increased risk remains unclear, however, because areal bone mineral density (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructural properties critical to determining bone quality and strength. To better define the skeletal effects of MGUS, we performed aBMD and high-resolution peripheral quantitative computed tomography volumetric bone mineral density (vBMD) measurements in 50 MGUS patients (20 females, 30 males; mean \u00b1 SEM age, 70.5 \u00b1 1.4 years) and 100 matched control subjects. Relative to controls, MGUS patients had decreased aBMD at the femoral neck (P = .05) and total femur (P &lt; .05) but no differences at other sites. In contrast, high-resolution peripheral quantitative computed tomography showed markedly diminished cortical thickness (P &lt; .05) and increased endocortical area (P &lt; .01). Average vBMD (P &lt; .01), cortical vBMD (P &lt; .001), and trabecular thickness (P &lt; .01) were all significantly decreased in MGUS patients, suggestive of impaired bone formation. Serum levels of the Wnt pathway inhibitor Dickkopf-related protein 1 (P &lt; .001) and osteoclast-activating factor MIP-1\u03b1 (P &lt; .05) also were significantly elevated in MGUS patients. Our data provide the first evidence of altered bone microstructure in MGUS and suggest that cytokines elevated in osteolytic myeloma also may be associated with bone loss in MGUS.<\/jats:p>","DOI":"10.1182\/blood-2011-04-351437","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T04:38:35Z","timestamp":1320122315000},"page":"6529-6534","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":72,"title":["Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1\u03b1 levels in patients with MGUS"],"prefix":"10.1182","volume":"118","author":[{"given":"Alvin C.","family":"Ng","sequence":"first","affiliation":[{"name":"Divisions of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthinee","family":"Charatcharoenwitthaya","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Divisions of Biomedical Statistics and Informatics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Holets","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise K.","family":"McCready","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"L. Joseph","family":"Melton","sequence":"additional","affiliation":[{"name":"Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Drake","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111808302186500_B1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study.","volume":"20","author":"Melton","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2019111808302186500_B2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"13","key":"2019111808302186500_B3","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111808302186500_B4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance.","volume":"19","author":"Melton","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2019111808302186500_B5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.bmt.1705307","article-title":"Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.","volume":"37","author":"O'Shea","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111808302186500_B6","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/ijc.22033","article-title":"Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.","volume":"119","author":"Politou","year":"2006","journal-title":"Int J Cancer"},{"issue":"9","key":"2019111808302186500_B7","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1182\/blood.V90.9.3743","article-title":"Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.","volume":"90","author":"Pecherstorfer","year":"1997","journal-title":"Blood"},{"issue":"5","key":"2019111808302186500_B8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1445-5994.2001.00055.x","article-title":"Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance.","volume":"31","author":"Diamond","year":"2001","journal-title":"Intern Med J"},{"issue":"4","key":"2019111808302186500_B9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02230356","article-title":"Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma.","volume":"15","author":"The Midi-Pyrenees Myeloma Group","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2019111808302186500_B10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","article-title":"Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance.","volume":"134","author":"Pepe","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111808302186500_B11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","article-title":"Fracture risk in patients with monoclonal gammopathy of undetermined significance.","volume":"135","author":"Gregersen","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111808302186500_B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000162282","article-title":"Prevalence of monoclonal gammopathy of undetermined significance\/myeloma in patients with acute osteoporotic vertebral fractures.","volume":"120","author":"Golombick","year":"2008","journal-title":"Acta Haematol"},{"key":"2019111808302186500_B13","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/BOT.0b013e31815e9fe1","article-title":"Quantification of bone structural parameters and mechanical competence at the distal radius.","volume":"22","author":"van Lenthe","year":"2008","journal-title":"J Orthop Trauma"},{"issue":"1","key":"2019111808302186500_B14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2003.04561.x","article-title":"Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma.","volume":"123","author":"Terpos","year":"2003","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111808302186500_B15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111808302186500_B16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","article-title":"Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites.","volume":"19","author":"Riggs","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2019111808302186500_B17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S8756-3282(97)00205-6","article-title":"Ridge number density: a new parameter for in vivo bone structure analysis.","volume":"21","author":"Laib","year":"1997","journal-title":"Bone"},{"issue":"5-6","key":"2019111808302186500_B18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/THC-1998-65-606","article-title":"In vivo high resolution 3D-QCT of the human forearm.","volume":"6","author":"Laib","year":"1998","journal-title":"Technol Health Care"},{"key":"2019111808302186500_B19","first-page":"53","article-title":"Stereologic basis of bone histomorphometry: theory of quantitative microscopy and reconstruction of the third dimension.","volume-title":"Bone Histomorphometry: Techniques and Interpretation","author":"Parfitt","year":"1983"},{"issue":"2","key":"2019111808302186500_B20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s001980200004","article-title":"New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images.","volume":"13","author":"Laib","year":"2002","journal-title":"Osteoporos Int"},{"issue":"1","key":"2019111808302186500_B21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S8756-3282(98)00159-8","article-title":"Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography.","volume":"24","author":"Laib","year":"1999","journal-title":"Bone"},{"issue":"10","key":"2019111808302186500_B22","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.medengphy.2006.11.002","article-title":"Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality.","volume":"29","author":"MacNeil","year":"2007","journal-title":"Med Eng Phys"},{"issue":"15","key":"2019111808302186500_B23","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"2019111808302186500_B24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1196\/annals.1346.039","article-title":"Bone strength: current concepts.","volume":"1068","author":"Turner","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"2019111808302186500_B25","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMcp070341","article-title":"Clinical practice. Osteopenia.","volume":"356","author":"Khosla","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111808302186500_B26","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/leu.2010.173","article-title":"The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.","volume":"24","author":"Terpos","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"2019111808302186500_B27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","article-title":"Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).","volume":"126","author":"Politou","year":"2004","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111808302186500_B28","first-page":"394","article-title":"Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.","volume":"86","author":"Corso","year":"2001","journal-title":"Haematologica"},{"issue":"11","key":"2019111808302186500_B29","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood.V87.11.4762.bloodjournal87114762","article-title":"Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies.","volume":"87","author":"Bataille","year":"1996","journal-title":"Blood"},{"issue":"11","key":"2019111808302186500_B30","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1210\/jc.2005-0794","article-title":"Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.","volume":"90","author":"Rogers","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"2019111808302186500_B31","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"2019111808302186500_B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases.","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"issue":"6","key":"2019111808302186500_B33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","article-title":"Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.","volume":"80","author":"Kaiser","year":"2008","journal-title":"Eur J Haematol"},{"issue":"6","key":"2019111808302186500_B34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.hoc.2007.08.005","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.","volume":"21","author":"Kyle","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"2019111808302186500_B35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00223-008-9145-2","article-title":"The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance.","volume":"82","author":"Pepe","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"19","key":"2019111808302186500_B36","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/1078-0432.CCR-08-0666","article-title":"Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss.","volume":"14","author":"Berenson","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2019111808302186500_B37","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/25\/6529\/1346266\/zh805111006529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/25\/6529\/1346266\/zh805111006529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:54:05Z","timestamp":1574085245000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/25\/6529\/29260\/Bone-microstructural-changes-revealed-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":37,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2011,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-351437","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}